Chemicals and menopause: Effects on age at menopause and on health status in the postmenopausal period

Journal of Women's Health

Volumn 8, Issue 2, 1999, Pages 227-234

  Silbergeld, Ellen K ^a   Flaws, Jodi A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; DRINKING WATER;

AGE; EARLY MENOPAUSE; FEMALE; HAZARDOUS WASTE; HEALTH STATUS; HUMAN; MENOPAUSE; MORBIDITY; MORTALITY; OVARY FOLLICLE; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK;

EID: 0033025501     PISSN: 10597115     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1999.8.227     Document Type: Review

References (68)

1. Sowers MR, La Pietra MT. Menopause: Its epidemiology and potential association with chronic disease. Epidemiol Rev 1995;17:287.
2. Wood JW. Dynamics of human reproduction: Biology, biometry, demography. New York: Aldine de Gruyter, 1994.
3. Matthews KA, Meilahn E, Kuller LH, et al. Menopause and risk factors for coronary heart disease. N Engl J Med 1989;321:641.
4. Dennerstein L. Depression in menopause. Obstet Gynecol Clin North Am 1987;14:33.
5. Nilas L, Christensen C. The pathophysiology of peri- and postmenopausal bone loss. Br J Obstet Gynaecol 1989;96:580.
6. Goemaere S, Ackerman C, Goethals K, et al. Onset of symptoms of rheumatoid arthritis in relation to age, sex, and menopausal transition. J Rheumatol 1990;17: 1620.
7. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988;13: 345.
8. Hui SI, Slemenda CW, Johnston CC, Appledorn CR. Effects of age and menopause on vertebral bone density. Bone Miner 1987;2:141.
9. Pector TD, Campion GD. Generalized osteoarthritis: A hormonally mediated disease. Ann Rheum Dis 1989; 48:523.
10. Bagur AC, Mautalen CA. Risk of developing osteoporosis in untreated premature menopause. Calcif Tissue Int 1992;51:4.
11. Browner WS, Pressman AR, Nevitt MC, et al. Association between low bone density and stroke in elderly women. Stroke 1993;24:940.
12. McKinlay JB, McKinlay SM, Brambilla D. The relative contributions of endocrine changes and social circumstances to depression in middle-aged women. J Health Soc Behav 1987;16:345.
13. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992;14:103.
14. Whelan EA, Sandler DP, McConnaughey R, et al. Menstrual and reproductive characteristics and age at natural menopause. Am J Epidemiol 1990;131:625.
15. Luoto R, Kaprio J, Uutela A. Age at natural menopause and sociodemographic status in Finland. Am J Epidemiol 1994;139:64.
16. van Keep PA, Brand PC, Lehert P. Factors affecting the age at menopause. J Biosoc Sci 1979;6(Suppl):37.
17. Veneman TF, Beverstock CG, Exalto N, Mollevanger P. Premature menopause because of an inherited deletion in the long arm of the X-chromosome. Fertil Steril 1991;55:631.
18. Cramer DW, Xu H, Harlow BL. Family history as a predictor of early menopause. Fertil Steril 1995;64:740.
19. Wise PM, Scarfrogh K, Lloyd J, et al. Neuroendocrine concomitants of reproductive aging. Exp Gerontol 1994;29:275.
20. Sherman BM, West JH, Korenman SG. The menopausal transition: Analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 1976;42:629.
21. Gosden R, Faddy MJ. Ovarian aging, follicular depletion, and steroidogenesis. Exp Gerontol 1994;29:265.
22. Al Azzawi F. Endocrinological aspects of the menopause. Br Med Bull 1992;48:262.
23. Flaws JA, Hirshfield AN. Reproductive, developmental and endocrine toxicology. In: Sipes IG, et al., eds. Comprehensive toxicology. 1997;283.
24. Neugarten BL, Kraines RJ. Menopausal symptoms in women of various ages. Psychosom Med 1965;27:266.
25. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67: 604.
26. Gardsell P, Johnell O, Nilsson BE. The impact of menopausal age on future fragility fracture risk. J Bone Miner 1991;6:429.
27. Kritz-Silverstein D, Barrett-Connor E. Early menopause, number of reproductive years, and bone mineral density in postmenopausal women. Am J Public Health 1993;83:983.
28. Cramer DW. Epidemiological aspects of early menopause and ovarian cancer. Am J Obstet Gynecol 1990; 99:155.
29. Snowdon DA, Kane RL, Beeson WL, et al. Is early natural menopause a biologic marker of health and aging? Am J Public Health 1989;79:709.
30. Wise PM, Krajnak KM, Kashon ML. Menopause: The aging of multiple pacemakers. Science 1996;273:67.
31. Wilkes MM, Lu KH, Fulton SL, Yen SS. Hypothalamic-pituitary-ovarian interactions during reproductive senescence in the rat. Adv Exp Med Biol 1978;113:127.
32. Chapman RM. Gonadal injury resulting from chemotherapy. Am J Ind Med 1983;4:149.
33. Warne GL, Fairly KF, Hobbs JB, Martin FIR. Cyclophosphamide-induced ovarian failure. N Engl J Med 1973;289:1159.
34. Hoyer PB, Sipes IG. Assessment of follicular destruction in chemical-induced ovarian toxicity. Ann Rev Pharmacol Toxicol 1996;36:307.
35. Dobson RL, Felton JS. Female germ cell loss from radiation and chemical exposures. Am J Ind Med 1983; 4:175.
36. Mattison DR, Shiromizu K, Nightingale MS. Oocyte destruction by polycyclic aromatic hydrocarbons. Am J Ind Med 1983;4:191.
37. Somkuti SG. Environmental and behavioral factors associated with decreased female fertility. Infert Reprod Med Clin North Am 1995;6:77.
38. Mattison DR, Takizawa K, Silbergeld EK, et al. Genetics of ovarian benzo(a)pyrene metabolism, oocyte destruction and impaired fertility. In: Sydstrom J, et al., eds. Extrahepatic drug metabolism and chemical carcinogenesis. Amsterdam: Elsevier, 1983:337.
39. Smith BJ, Carter DE, Sipes IG. Comparison of the disposition and in vitro metabolism of 4-vinylcyclohexene in the female mouse and rat. Toxicol Appl Pharmacol 1990;105:364.
40. Flaws JA, Doerr JK, Sipes IG, Hoyer PB. Destruction of preantral follicles in adult rats by 4-vinyl-1-cyclohexene diepoxide. Reprod Toxicol 1994;8:509.
41. Meredith S, Kirkpatrick-Keller D, Butcher RL. Effects of food restriction and hypophysectomy on numbers of primordial follicles and concentrations of hormones in rats. Biol Reprod 1986;35:68.
42. Dixon R. Reproductive toxicology. New York: Liss, 1985.
43. Colborn T, vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 1993;102(Suppl 2):126.
44. Cooper RL, Kavlock RJ. Endocrine disruptors and reproductive development: A weight-of-evidence overview. J Endocrinol 1997;152:159.
45. Colborn T, Dumanoski D, Myers JP. Our stolen future. New York: Penguin Books, 1995.
46. Everson RB, Sandler DP, Wilcox AJ, et al. Effect of passive exposure to smoking on age at natural menopause. Br Med J 1986;293:792.
47. Kaufman DW, Slone D, Rosenberg L, Miettinen OS, Shapiro S. Cigarette smoking and age at natural menopause. Am J Public Health 1980;70:420.
48. Vahakangas K, Rajaniemi H, Pelkonen O. Ovarian toxicity of cigarette smoke exposure during pregnancy in mice. Toxicol Lett 1985;25:75.
49. Cooper GS, Baird DD, Hulka BS, et al. Follicle-stimulating hormone concentrations in relation to active and passive smoking. Obstet Gynecol 1995;85:407.
50. Looker AC, Wahner WH, Dunn WL, et al. Proximal femur bone mineral levels of U.S. adults. Osteoporosis Int 1995;5:389.
51. Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1988;7:178.
52. Bhattacharyya MH, Jeffery E, Silbergeld EK. Bone metabolism: Effects of essential and toxic trace metals. In: Waalkes M, Klaasen CD, eds. Metal toxicology. Boca Raton, FL: CRC Press, 1996;959.
53. Staropoli CA, Flaws JA, Bush TL, Moulton AW. Cigarette smoking and frequency of menopausal hot flashes (abstract). Am J Epidemiol 71, 1997;71.
54. Smith EM, Hammonds-Ehlers M, Clark MK, Kirchner HL, Fuortes L. Occupational exposures and risk of female infertility. J Occup Environ Med 1997;39:138.
55. Mattison DR, Plowchalk DR, Meadows MJ, et al. Reproductive toxicity: Male and female reproductive systems as targets for chemical injury. Med Clin North Am 1990;74:391.
56. Deane M, Swan SH, Harris JA, Epstein DM, Neutra RR. Adverse pregnancy outcomes in relation to water contamination, Santa Clara County, California, 1980-1981. Am J Epidemiol 1989;129:894.
57. Burg JA, Gist GL. The potential impact on women from environmental exposures. J Women's Health 1997;6:159.
58. Fowler BA, Silbergeld EK. Impact of new technologies on occupational medicine. Ann NY Acad Sci 1989;572:46.
59. Correa A, Gray RH, Cohen R, et al. Ethylene glycol ethers and risks of spontaneous abortion and subfertility. Am J Epidemiol 1996;143:707.
60. Swan SH, Beaumont JJ, Hammond SK, et al. Historical cohort study of spontaneous abortion among fabrication workers in the semiconductor health study: Agent-level analysis. Am J Ind Med 1995;28:751.
61. Swartz WJ, Mall GM. Chlordecone-induced follicular toxicity in mouse ovaries. Reprod Toxicol 1989;3:203.
62. Brambilla DJ, McKinlay SM, Johnannes CB. Defining the perimenopause for application in epidemiologic investigations. Am J Epidemiol 1994;140:1091.
63. Correa A, Stewart WF, Yeh HC. Exposure measurement in case-control studies: Reported methods and recommendations. Epidemiol Rev 1994;16:18.
64. Flint M. Is there a secular trend in age of menopause? Maturitas 1978;1:133.
65. Martin MC, Block JE, Sanchez SD, Arnaud CD, Beyene Y. Menopause without symptoms: The endocrinology of menopause among rural Mayan Indians. Am J Obstet Gynecol 1993;168:1839.
66. Avis NE, Crawford SL, McKinlay SM. Psychosocial, behavioral, and health factors related to menopause symptomatology. Women's Health 1997;3:103.
67. Kay M, Voda A, Olivas G, Rios F, Imle M. Ethnography of the menopause-related hot flash. Maturitas 1982;4:217.
68. Wilbur J, Miller A, Montgomery A. The influence of demographic characteristics, menopausal status, and symptoms on women's attitudes toward menopause. Women and Health 1995;23:19.